Pharmacy Technology

WHAT IT MEANS AND WHY IT'S IMPORTANT In these times of trillion-dollar spending bills and massive deficits, $16 billion may not seem like all that much. But it’s enough to throw another critical lifeline to states coping with the ever-rising costs of Medicaid health assistance to the poor and unemployed –– and to thousands of community pharmacies that have to provide prescription services to those millions of Americans.

CHICAGO G Cubed’s Toe Juice was voted Best New Product on Tuesday by retail buyers attending the ECRM Health Care EPPS show.

 

The Best New Product award is sponsored by Drug Store News.

 

 

Toe Juice, formulated with DemaVine, a blend of plant extracts, is a fast-drying liquid that helps soothe itching and burning feet and refresh and soften dry cracked skin.

 

 

WHAT IT MEANS AND WHY IT'S IMPORTANT In the ever-evolving world of food retailing, two developments stood out last week.

(THE NEWS: Walgreens continues fight against food deserts in Chicago. For the full story, click here)

LOS ANGELES A new study looking at the role probiotics may play in increasing CD4 cell count in people with HIV is under way at the AIDS Healthcare Foundation, the foundation announced Tuesday.

 

Researchers at the AHF hypothesized that probiotic consumption may reduce leakage of Gram-negative bacteria from the intestine, thereby reducing the resulting inflammatory response and destruction of CD4 cells.

 

 

WASHINGTON The companies working on more than half of the mental illness drugs under development are clustered in four U.S. states, according to research by the largest lobby for the drug industry.

 

The Pharmaceutical Research and Manufacturers of America compiled a study showing that of the 313 drugs, 192 are under development by companies in New York, New Jersey, North Carolina and California. The drugs are in clinical trials or under review by the Food and Drug Administration, PhRMA said.

 

 

SALT LAKE CITY Prolatis earlier this week announced a voluntary nationwide recall of the company’s product sold under the brand name Prolatis’ after being informed by the Food and Drug Administration that lab analysis has found their male-enhancement products to contain sulfoaildenafil, an analogue of sildenafil, an FDA-approved drug used as treatment for male erectile dysfunction.

 

That makes Prolatis’ an unapproved drug, as opposed to a dietary supplement.